Merck's profit jumps 12% on 24% sales increase
Article Abstract:
Merck & Co. posted an improvement of 12% in net income for the second-quarter of 1999. The company's income were what analysts had expected. Merck benefited from strong osteoporosis, high-blood pressure, and arthritis drug sales. The company reported $1.48 billion (1.41 billin euros) in net income for the quarter. Merck's sales also improved 24% to $8.02 billion.
Comment:
Posts improvement of 12% in net income for second-quarter of 1999
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
AstraZeneca says it expects to meet annual forecast
Article Abstract:
AstraZeneca PLC predicted that it will meet its yearly targets for the 2001 year. The company has been performing well during the 2001 year as of the month of December.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Letsbuyit expects losses to narrow. Barnes & Noble.com expects to report 23% revenue rise. Barnes & Noble warns that profit will miss target
- Abstracts: Intel's profit leaps 57% in quarter. Agere repays part of debt
- Abstracts: Novartis's net profit rises 13%, driven by a 19% sales increase. Swiss Life Shares Will Be Comatose Until Markets Revive
- Abstracts: SkyePharma's loss widened in first half. Bioglan's wrangling may be tied to deal
- Abstracts: Air France's earnings soared in quarter. KLM Airlines adds surcharge to offset costs. French Concordes will continue to be grounded